Picture of Quantum Genomics SA logo

ALQGC — Quantum Genomics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Quantum Genomics Gets Approval For Firibastat Clinical Evaluation

Oct 18 (Reuters) - QUANTUM GENOMICS SA  ALQGC.PA :
    * OBTAINS APPROVAL FROM ETHICS COMMITTEE FOR LAUNCH CLINICAL
EVALUATION OF EXTENDED-RELEASE FIRIBASTAT TABLETS
    * THE RESULTS OF THIS STUDY WILL BE AVAILABLE IN THE COURSE
OF 2
QUARTER 2019

Source text for Eikon:  ID:nACT55605 
Further company coverage:  ALQGC.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))

Recent news on Quantum Genomics SA

See all news